Aaron Rosenberg
Vermögen: 9 Mio $ am 31.07.2026
Vermögen: 9 Mio $ am 31.07.2026
Aaron Rosenberg currently serves as Treasurer, Director & Senior Vice President at ArQule, Inc., Treasurer & Director at Harrisvaccines LLC, Treasurer, Director & Senior Vice President at Imago BioSciences, Inc., Director at Prometheus Biosciences, Inc., and Chief Financial Officer at BeOne Medicines Ltd. Formerly, Mr. Rosenberg was Treasurer, Director & Senior Vice President at Acceleron Pharma, Inc. and Treasurer & Senior Vice President at Merck & Co., Inc. from 2018 to 2024.
Education includes an MBA from The Leonard N Stern School of Business and an undergraduate degree from Warrington College of Business Administration.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BEONE MEDICINES LTD. 0,03 % | 03.08.2026 | 382.850 ( 0,03 % ) | 9 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BEIGENE LTD | Finanzdirektor/CFO | 22.07.2024 |
| ARQULE, INC. | Direktor/Vorstandsmitglied | - |
| IMAGO BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 11.01.2023 |
| PROMETHEUS BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 16.06.2023 |
Harrisvaccines LLC
Harrisvaccines LLC BiotechnologyHealth Technology Develops vaccine technology for the treatment and prevention of infectious diseases in swine and cattle | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | Treasurer | 01.07.2024 |
| ACCELERON PHARMA INC. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Harrisvaccines LLC
Harrisvaccines LLC BiotechnologyHealth Technology Develops vaccine technology for the treatment and prevention of infectious diseases in swine and cattle | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warrington College of Business Administration
Warrington College of Business Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imago BioSciences, Inc.
Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen